Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01156298 · ClinicalTrials.gov registry record
Controlled High Risk AVONEX® Multiple Sclerosis Prevention Study In Ongoing Neurological Surveillance
A clinical trial, sponsored by Biogen.
- Terminated
- Registry status
- 383
- Enrollment target
NCT01156298: Clinical Trial study, sponsored by Biogen.
NCT01156298 is a clinical trial that was terminated before completion, run by Biogen. The registered enrollment target is 383 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01156298 was terminated before completion, sponsored by Biogen.
- TERMINATED
- Registry status
- 383 participants
- Enrollment target
Study Summary
Phase IV, multi-center, non-treatment, observational, registry study to determine long term effects of AVONEX® therapy on EDSS, MRI, QoL, and cognition.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 383 participants |
| Start Date | 2010-06 |
| Est. Completion | 2017-03 |
Why NCT01156298 stopped before completion
NCT01156298 is an observational study that tracks outcomes without assigning an intervention. The registered 383 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01156298 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01156298 about?
NCT01156298 is a clinical study titled "Controlled High Risk AVONEX® Multiple Sclerosis Prevention Study In Ongoing Neurological Surveillance". Phase IV, multi-center, non-treatment, observational, registry study to determine long term effects of AVONEX® therapy on EDSS, MRI, QoL, and cognition.
What is the current status of trial NCT01156298?
This trial is currently terminated. The enrollment target is 383 participants. The study started on 2010-06. Estimated completion is 2017-03.
Who is sponsoring clinical trial NCT01156298?
This trial is sponsored by Biogen, which has 334 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06056830 · 383 participants · Phase 3
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- NCT06277661 · 384 participants · NA
The Mom and Infant Outcomes (MOMI) Study
- NCT06372964 · 384 participants · Phase 3
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- NCT06501040 · 384 participants · NA
Increasing Knowledge and Interest in Cancer Clinical Trials
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia